These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 16230262)

  • 1. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Takabatake N; Okuyama H; Fukui A; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Takahashi H; Koyama Y; Kubota I
    J Card Fail; 2005 Oct; 11(8):595-601. PubMed ID: 16230262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin-C and mortality in elderly persons with heart failure.
    Shlipak MG; Katz R; Fried LF; Jenny NS; Stehman-Breen C; Newman AB; Siscovick D; Psaty BM; Sarnak MJ
    J Am Coll Cardiol; 2005 Jan; 45(2):268-71. PubMed ID: 15653026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of cystatin C and prognosis following admission for acute heart failure.
    Campbell CY; Clarke W; Park H; Haq N; Barone BB; Brotman DJ
    Am J Cardiol; 2009 Aug; 104(3):389-92. PubMed ID: 19616673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction.
    Carrasco-Sánchez FJ; Galisteo-Almeda L; Páez-Rubio I; Martínez-Marcos FJ; Camacho-Vázquez C; Ruiz-Frutos C; Pujol-De La Llave E
    J Card Fail; 2011 Jan; 17(1):31-8. PubMed ID: 21187262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients.
    Villa P; Jiménez M; Soriano MC; Manzanares J; Casasnovas P
    Crit Care; 2005 Apr; 9(2):R139-43. PubMed ID: 15774046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome.
    Jernberg T; Lindahl B; James S; Larsson A; Hansson LO; Wallentin L
    Circulation; 2004 Oct; 110(16):2342-8. PubMed ID: 15477399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
    Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
    Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
    Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
    Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure.
    Aronson D; Mittleman MA; Burger AJ
    Am J Med; 2004 Apr; 116(7):466-73. PubMed ID: 15047036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C and the risk of death and cardiovascular events among elderly persons.
    Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
    N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes.
    Macisaac RJ; Tsalamandris C; Thomas MC; Premaratne E; Panagiotopoulos S; Smith TJ; Poon A; Jenkins MA; Ratnaike SI; Power DA; Jerums G
    Diabet Med; 2007 Apr; 24(4):443-8. PubMed ID: 17388960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Ren Fail; 2008; 30(2):181-6. PubMed ID: 18300118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cystatin C as a marker of glomerular filtration rate in patients with ovarian cancer].
    Bodnar L; Wcisło GB; elichowski G; Raczka A; Wańkowicz Z; Szczylik C
    Pol Merkur Lekarski; 2008 Apr; 24(142):307-11. PubMed ID: 18634361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.
    Kawai K; Kawashima S; Miyazaki T; Tajiri E; Mori M; Kitazaki K; Shirotani T; Inatome T; Yamabe H; Hirata K; Yokoyama M
    J Cardiol; 2010 Jan; 55(1):99-107. PubMed ID: 20122555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.